Shimadzu Corporation announces application of mass microscope technology for molecular imaging of anticancer drug action

In a collaborative study with the National Cancer Center, nano-surface and molecular-orientation limited (nSMOL) proteolysis of antitumor antibodies was used to determine their effective concentration in tumor tissue. The method will be further developed to visualize the pharmacokinetics of other drugs

Shimadzu Corporation news release, December 18, 2013

Shimadzu Corporation announces application of mass microscope technology for molecular imaging of anticancer drug action
Scroll to top